Boulder Diagnostics

Boulder Diagnostics Overview

Founded 2009
Founded
Status Acquired/​Merged
Latest Deal Type M&A
Latest Deal Amount $7.9M
Latest Deal Amount

Boulder Diagnostics General Information

Description

Developer of immunology-based assays designed to treat rheumatology and infectious diseases. The company is primarily engaged in developing diagnostic reagents and tests for infectious diseases and other protein targets.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 6395 Gunpark Drive
  • Suite W
  • Boulder, CO 80301
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Boulder Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 31-Jul-2014 $7.9M 00.00 Completed Generating Revenue
1. Early Stage VC Completed Startup

Boulder Diagnostics Executive Team (3)

Name Title Board Seat Contact Info
Roy Mondesire Ph.D Scientific Consultant

2 Former Executives

Boulder Diagnostics Former Investors (2)

To view Boulder Diagnostics‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Reich Consulting Venture Capital Minority 000 0000 000000 0
Ventac Partners Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial